Selected article for: "bronchoalveolar lavage and endotracheal aspirate"

Author: Neves, Cynthia Pessoa; Costa, Allyson Guimarães; Safe, Izabella Picinin; de Souza Brito, Alexandra; Jesus, Jaquelane Silva; Kritski, Afranio Lineu; Lacerda, Marcus Vinicius Guimarães; Viveiros, Miguel; Cordeiro-Santos, Marcelo
Title: The role of mini-bronchoalveolar lavage fluid in the diagnosis of pulmonary tuberculosis in critically ill patients
  • Cord-id: 20efj91n
  • Document date: 2020_3_18
  • ID: 20efj91n
    Snippet: BACKGROUND: The detection of Mycobacterium tuberculosis (MTB) in the intensive care unit (ICU) presents several challenges, mainly associated to the clinical state of the patient. The presence of HIV infection further aggravates this scenario, requiring a reliable collection method, with better performance in the microbiological/molecular techniques to be used. We evaluated the performance of two methods for sample collection, mini bronchoalveolar lavage (Mini-BAL) and endotracheal aspirate (ETA
    Document: BACKGROUND: The detection of Mycobacterium tuberculosis (MTB) in the intensive care unit (ICU) presents several challenges, mainly associated to the clinical state of the patient. The presence of HIV infection further aggravates this scenario, requiring a reliable collection method, with better performance in the microbiological/molecular techniques to be used. We evaluated the performance of two methods for sample collection, mini bronchoalveolar lavage (Mini-BAL) and endotracheal aspirate (ETA), for diagnosis of pulmonary tuberculosis (PTB) in critically ill patients. METHODS: This prospective study involved 26 HIV positive ICU internalized patients, with presumptive PTB who required mechanical ventilation. Two samples were obtained prospectively from 26 HIV ICU patients with presumptive PTB by Mini-BAL and ETA. The samples were processed for smear microscopy, Löwenstein-Jensen medium and the BACTEC Mycobacteria Growth Indicator Tube 960 system®. We define as confirmed PTB patients with positive MTB culture. Furthermore, all samples obtained through the Mini-BAL were analyzed by Xpert® MTB/RIF. RESULTS: Our results demonstrated that the respiratory samples obtained by Mini-BAL were able to increase MTB detection in critically ill patients with presumptive PTB. The Mini-BAL allowed 30% increased recovery and guaranteed enough sample volume for processing in all methods. In addition, the larger volume of the samples obtained with this technique enabled the Xpert® MTB/RIF molecular test for diagnosis of TB. CONCLUSIONS: The Mini-BAL showed be an acceptable alternative to ETA in this population, since these critically ill and often-immunocompromised patients are more likely to develop complications related to invasive procedures.

    Search related documents:
    Co phrase search for related documents
    • acceptable alternative and low income: 1
    • active respiratory tb failure and acute respiratory distress syndrome: 1
    • active respiratory tb failure and acute respiratory failure: 1, 2
    • active respiratory tb failure patient and acute respiratory failure: 1
    • active tuberculosis and acute respiratory distress syndrome: 1, 2, 3
    • active tuberculosis and acute respiratory failure: 1, 2, 3
    • active tuberculosis and low income: 1, 2, 3, 4
    • active tuberculosis and low income middle: 1, 2
    • active tuberculosis and low respiratory: 1
    • acute respiratory distress syndrome and long suction: 1
    • acute respiratory distress syndrome and long suction catheter: 1
    • acute respiratory distress syndrome and low cost invasive: 1
    • acute respiratory distress syndrome and low income: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory distress syndrome and low income middle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory distress syndrome and low income middle country: 1
    • acute respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory failure and low cost invasive: 1
    • acute respiratory failure and low income: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory failure and low income middle: 1, 2, 3, 4, 5